Financhill
Back

Catalyst Pharmaceuticals Vs. Cytokinetics Industry Stock Comparison

Sell
42

CPRX
Catalyst Pharmaceuticals

Last Price:
14.71
Seasonality Move:
10.94%
Buy
60

CYTK
Cytokinetics

Last Price:
65.33
Seasonality Move:
12.64%
Sell
42
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $14.72. The Score for CPRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $65.27. The Score for CYTK is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $14.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $65.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 42.69 Sell
Chaikin Money Flow: -1085975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.93 - 15.65) Sell
Bollinger Bands (100): (14.1 - 16.22) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 44.9 Sell
Chaikin Money Flow: -597314 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.53 - 72.31) Sell
Bollinger Bands (100): (56.66 - 85.4) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.99 Sell
20-day SMA: 15.27 Sell
50-day SMA: 15.62 Sell
200-day SMA: 14.25 Buy
8-day EMA: 15.01 Sell
20-day EMA: 15.2 Sell
50-day EMA: 15.28 Sell
200-day EMA: 14.61 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.23 Buy
20-day SMA: 67.68 Sell
50-day SMA: 68.73 Sell
200-day SMA: 51.98 Buy
8-day EMA: 64.61 Buy
20-day EMA: 66.43 Sell
50-day EMA: 68.25 Sell
200-day EMA: 57.69 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $1.28 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):